Understanding Dapoxetine 60mg for Premature Ejaculation

Dapoxetin > dapoxetine 60 mg tablets


The non-pharmacological therapies included

Trial Snapshot

Multivariate analysis revealed clear separations in metabolic profiles between the PPE and HC groups, and between dapoxetine treatment (DT)-Response and DT-No response groups. Pathway analysis indicated significant enrichment in amino acid metabolism pathways for PPE-related differentially expressed metabolites (DEMs). Additionally, DT-Response-related DEMs were associated with D-Amino acid metabolism and Arginine biosynthesis. Machine learning identified a panel of 4 consensus metabolites for diagnosing PPE, achieving an area under the curve (AUC) of 0.995 in the train cohort and 0.917 in the test cohort. For predicting DT response, three metabolites were selected, forming a model with an AUC of 0.905 dapoxetine 30mg tablet (train) and 0.811 (test).

Drug-related adverse effects (AEs)

It is important to note that these promising initial results require further validation in larger, independent cohorts to confirm their generalizability. Furthermore, targeted metabolomics analysis confirmed significant dysregulation of multiple neurotransmitters in the PPE group. The machine learning-based models we established show robust performance in diagnostic and dapoxetine treatment response prediction. The establishment of the machine learning-based diagnostic and predictive models represents a key strength, though their clinical translation requires further validation in larger cohorts. This study delineates distinct metabolic profiles in PPE, establishes robust machine learning-based models for diagnosis and DT-Response prediction, and reveals the involvement of neurotransmitter dysregulation in its pathophysiology.

Patient-reported global impression of change (PGIC)

01 Feb 2026·JOURNAL OF CLINICAL PHARMACOLOGY Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects Author: Wu, Tong ; Wang, Yiming ; Qiu, Wen ; Bai, Fuqiang ; Lu, Haobo ; Pu, Libin ; Gao, Yuan Dapoxetine is a short‐acting selective serotonin reuptake inhibitor used to treat premature ejaculation. However, its clinical effectiveness is challenged by substantial inter‐individual variability in pharmacokinetics, as both the drug's therapeutic efficacy and the incidence of adverse reactions are highly dependent on its exposure. This study aims to develop a population pharmacokinetic model for dapoxetine, to investigate the sources of the variability, and to identify demographic and pharmacogenetic factors that influence drug exposure. The pharmacokinetic data for this analysis were obtained from a bioequivalence study conducted in 39 healthy Chinese male subjects. As part of this study, all volunteers were genotyped for the CYP3A4*1G, CYP3A5*3, CYP2D6*10, and CYP2D6*41 allelic variants. shockwave therapy, biofeedback, electric stimulation,

pelvic floor muscle training, desensitization

User Feedback Aspect Average Rating (out of 5) Comments Notes
Effectiveness 4.2 Improved control over ejaculation Consistent results reported
Onset of Action 4.5 Usually within 1-2 hours Fast-acting
Side Effects 3.8 Mild nausea or dizziness occasional Generally well-tolerated
Overall Satisfaction 4.1 Positive experiences overall Widely used by satisfied users

techniques, psychotherapy, and behavioral therapy.

Contraindication Explanation Precautionary Measures
Severe hepatic impairment Impaired drug metabolism Dose adjustment or avoid use
Concurrent use with MAO inhibitors Risk of serotonin syndrome Discontinue MAO inhibitors before use
Heart problems Potential cardiovascular side effects Consult physician before use
Allergies to dapoxetine or excipients Possible allergic reactions Discontinue and seek medical advice

This systematic review and meta-analysis indicate

Product Dosage Quantity + Bonus Price
Priligy Generic Dapoxetine60mg60 + 8 Pills183.06€ 174.34€
Priligy Generic Dapoxetine60mg120 + 10 Pills341.26€ 325.01€
Priligy Generic Dapoxetine60mg30 + 6 Pills106.65€ 101.57€
Priligy Generic Dapoxetine60mg20 + 4 Pills77.31€ 73.63€
Priligy Generic Dapoxetine60mg10 Pills47.63€ 45.36€
Priligy Generic Dapoxetine60mg180 + 10 Pills494.76€ 471.20€
Viagra Original100mg8 Pills59.84€ 56.99€
Priligy Generic Dapoxetine60mg90 + 10 Pills265.64€ 252.99€
Viagra Oral Jelly100mg21 Sachets78.66€ 74.91€
Kamagra Polo100mg272 + 12 Pills622.94€ 593.28€
Viagra Generic150mg180 + 10 Pills236.46€ 225.20€

that while dapoxetine is recognized for its

Chống chỉ định

Dapoxetine, under the brand name Priligy, has been patented in the UK, allowing only certain distributors access. However, more affordable generics are expected to surface post-patent expiry (2024), providing a more cost-effective solution. Certain NHS areas do indeed offer Priligy prescriptions. Connecting with a local GP for details on NHS and private prescription options is always advised. Dapoxetine increases the intravaginal ejaculatory latency time, though exact times can vary based on individual responses.

Mechanism of action

Dapoxetine has undergone placebo-controlled clinical trials, with results indicating a high satisfaction rate. Most men reported an improvement in premature ejaculation symptoms and a tadalafil with dapoxetine tablets reduction in personal distress related to ejaculation. Secondary objective: To investigate the safety of a single 60 mg dose of the test formulation or the reference formulation in healthy volunteers. Bioequivalence study of Dapoxetine 60 mg Generic versus Priligy (Menarini) Tablet after single oral dosing in healthy volunteers Study on the efficacy and safety of rTMS combined with dapoxetine hydrochloride in the treatment of premature ejaculation 100 Clinical Results associated with Dapoxetine Hydrochloride 100 Translational Medicine associated with Dapoxetine Hydrochloride 100 Patents (Medical) associated with Dapoxetine Hydrochloride 06 Feb 2026·Journal of Sexual Medicine A prospective multicenter study on plasma metabolomics and machine learning for diagnosing premature ejaculation and predicting dapoxetine treatment response Author: Zhang, Qijie ; Shao, Wenchuan ; Luan, Jiaochen ; Xia, Jiadong ; Yang, Yuehua ; Dai, Yutian ; Song, Ninghong ; Xu, Chunlu Premature ejaculation is a prevalent sexual dysfunction, yet the variable patient response to first-line dapoxetine treatment poses a major clinical challenge, highlighting the unmet need for biomarkers to guide diagnosis and therapy. This study aimed to investigate the distinct plasma metabolic profile of primary premature ejaculation (PPE) patients, and to develop machine learning-based diagnostic and therapeutic response prediction models.

Intravaginal ejaculatory latency time (IELT)

A multicenter cohort comprising 69 patients with PPE and 51 healthy control (HC) subjects was enrolled. Differentially expressed metabolites were identified, and pathway enrichment analyses were conducted using Small Molecule Pathway Database and Kyoto Encyclopedia of Genes and Genomes. Three machine learning algorithms—Support Vector Machine, Random Forest, and Least Absolute Shrinkage and Selection Operator regression—were employed to screen biomarkers. Subsequently, targeted metabolomics analysis was used to quantify neurotransmitter levels. The primary outcomes included the Premature Ejaculation Diagnostic Tool, the intravaginal ejaculation latency time, and the Clinical Global Impression of Change scale score after a 4-week observation period of on-demand dapoxetine treatment. beneficial effects, its clinical efficacy is

significantly enhanced when combined with non-pharmacological interventions.